P. C. Weber

639 total citations
26 papers, 433 citations indexed

About

P. C. Weber is a scholar working on Endocrinology, Diabetes and Metabolism, Pharmacology and Biochemistry. According to data from OpenAlex, P. C. Weber has authored 26 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Pharmacology and 7 papers in Biochemistry. Recurrent topics in P. C. Weber's work include Eicosanoids and Hypertension Pharmacology (7 papers), Hormonal Regulation and Hypertension (7 papers) and Nitric Oxide and Endothelin Effects (4 papers). P. C. Weber is often cited by papers focused on Eicosanoids and Hypertension Pharmacology (7 papers), Hormonal Regulation and Hypertension (7 papers) and Nitric Oxide and Endothelin Effects (4 papers). P. C. Weber collaborates with scholars based in Germany, United States and Italy. P. C. Weber's co-authors include Reinhard Lorenz, Peter Roth, Wolfgang Siess, Waltraud M. Uedelhoven, Decio Armanini, Ursula Kuhnle, Joseph V. Bonventre, J H Gronich, Stephan Endres and G. Bechtner and has published in prestigious journals such as Circulation, The Journal of Clinical Endocrinology & Metabolism and Neurology.

In The Last Decade

P. C. Weber

24 papers receiving 401 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. C. Weber Germany 12 123 104 94 70 64 26 433
Allison B. Lehtinen United States 13 126 1.0× 106 1.0× 158 1.7× 57 0.8× 38 0.6× 16 508
Mariapina Pomilio Italy 10 138 1.1× 147 1.4× 73 0.8× 68 1.0× 30 0.5× 11 567
A L Blumberg Switzerland 10 106 0.9× 64 0.6× 107 1.1× 26 0.4× 59 0.9× 17 361
Lawrence Levine United States 6 209 1.7× 64 0.6× 118 1.3× 64 0.9× 59 0.9× 8 415
P.E. Jennings United Kingdom 11 60 0.5× 216 2.1× 117 1.2× 39 0.6× 35 0.5× 19 515
J A Lawson Australia 13 96 0.8× 126 1.2× 152 1.6× 35 0.5× 24 0.4× 18 613
Lucinda M. Wead United States 9 152 1.2× 72 0.7× 91 1.0× 30 0.4× 26 0.4× 9 415
Glenn Solis United States 12 145 1.2× 71 0.7× 125 1.3× 51 0.7× 41 0.6× 14 437
Kensaku Maeda Japan 13 295 2.4× 138 1.3× 157 1.7× 65 0.9× 37 0.6× 22 664
J. W. Strandhoy United States 14 200 1.6× 166 1.6× 248 2.6× 42 0.6× 96 1.5× 26 614

Countries citing papers authored by P. C. Weber

Since Specialization
Citations

This map shows the geographic impact of P. C. Weber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. C. Weber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. C. Weber more than expected).

Fields of papers citing papers by P. C. Weber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. C. Weber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. C. Weber. The network helps show where P. C. Weber may publish in the future.

Co-authorship network of co-authors of P. C. Weber

This figure shows the co-authorship network connecting the top 25 collaborators of P. C. Weber. A scholar is included among the top collaborators of P. C. Weber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. C. Weber. P. C. Weber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Weber, P. C.. (2015). Renal Prostaglandins, Kidney Function and Essential Hypertension1. Contributions to nephrology. 23. 83–92. 1 indexed citations
2.
Dill, Patricia, Moritz Wagner, A. R. Somerville, et al.. (2012). Child Neurology: Paroxysmal stiffening, upward gaze, and hypotonia. Neurology. 78(5). e29–32. 21 indexed citations
3.
Sellmayer, Alois, K. Theisen, & P. C. Weber. (2000). Omega-3-Fettsäuren nach Myokardinfarkt: Senkung der Mortalität durch antiarrhythmische Effekte. DMW - Deutsche Medizinische Wochenschrift. 125(50). 1542–1546.
4.
Weber, P. C., et al.. (1995). [Use of creatine phosphate in treatment of cardiocerebral syndrome associated with acute myocardial infarct in the aged].. PubMed. 134(2). 53–6. 3 indexed citations
5.
Sellmayer, Alois, C. W. Weber, P. C. Weber, et al.. (1993). Modulation of cell activation by n-3 fatty acids.. 21–30. 6 indexed citations
6.
Weber, P. C., et al.. (1992). [Glucose tolerance in the elderly--changes in insulin, C-peptide and glucagon secretion].. PubMed. 142(4). 73–8. 2 indexed citations
7.
Lorenz, Reinhard & P. C. Weber. (1992). Thromboxane as diagnostic tool and therapeutic target in cardiovascular disease.. PubMed. 5 Suppl. S53–5. 1 indexed citations
8.
9.
Dugrillon, A., G. Bechtner, Waltraud M. Uedelhoven, P. C. Weber, & Roland Gärtner. (1990). Evidence that an Iodolactone Mediates the Inhibitory Effect of Iodide on Thyroid Cell Proliferation but not on Adenosine 3′,5′-Monophosphate Formation. Endocrinology. 127(1). 337–343. 39 indexed citations
10.
Lorenz, Reinhard, et al.. (1989). Superior antiplatelet action of alternate day pulsed dosing versus split dose administration of aspirin. The American Journal of Cardiology. 64(18). 1185–1188. 28 indexed citations
11.
Wehling, Martin, Ursula Kuhnle, H. Witzgall, P. C. Weber, & Decio Armanini. (1988). LACK OF EFFECT OF ALDOSTERONE ON INTRACELLULAR SODIUM AND POTASSIUM IN MONONUCLEAR LEUCOCYTES FROM PATIENTS WITH PSEUDOHYPOALDOSTERONISM. Clinical Endocrinology. 28(1). 67–74. 15 indexed citations
12.
Armanini, Decio, Stephan Endres, Ursula Kuhnle, & P. C. Weber. (1988). Parallel determination of mineralocorticoid and glucocorticoid receptors in T- and B-lymphocytes of human spleen. European Journal of Endocrinology. 118(4). 479–482. 35 indexed citations
13.
Sellmayer, Alois, Th. Strasser, F. Spelsberg, & P. C. Weber. (1987). Increased Leukotriene B4Synthesis in Patients with Primary Hyperparathyroidism Is Normalized after Parathyroidectomy: A Study Comparing Parathyfoidectomy to Thyroid Adenomectomy*. The Journal of Clinical Endocrinology & Metabolism. 64(2). 387–390. 5 indexed citations
14.
Armanini, Decio, Ursula Kuhnle, H. Witzgall, et al.. (1986). The Determination of Mineralocorticoid Receptors in Human Mononuclear Leukocytes from Patients with Mineralocorticoid Excess: Physiological and Pathological Implications. Clinical and Experimental Hypertension Part A Theory and Practice. 8(4-5). 781–785. 3 indexed citations
15.
Armanini, Decio, H. Witzgall, Thomas Strasser, & P. C. Weber. (1985). Mineralocorticoid and Glucocorticoid Receptors in Circulating Mononuclear Leukocytes of Patients with Primary Hyperaldosteronism. Cardiology. 72(1). 99–101. 10 indexed citations
16.
Weber, P. C. & Susan M. Fischer. (1984). Arachidonic acid and eicosapentaenoic acid metabolism in platelets and vessel walls.. PubMed. 62(2). 129–129. 4 indexed citations
17.
Landgraf-Leurs, M. M. C., et al.. (1982). Aggregation and thromboxane formation by platelets and vascular prostacyclin production from BB rats. An animal model for type I diabetes. Prostaglandins. 24(1). 35–46. 21 indexed citations
18.
Oelkers, W., et al.. (1981). ACTH Stimulates Plasma Renin and Angiotensin II in Man. Clinical Science. 61(s7). 273s–275s. 4 indexed citations
19.
Weber, P. C., B. Scherer, E. Held, & Wolfgang Siess. (1980). Reduction of renal prostaglandin E formation in essential hypertension.. PubMed. 7. 1145–8. 3 indexed citations
20.
Änggård, Erik, Carin Larsson, & P. C. Weber. (1976). Interactions between the renal prostaglandins and the renin--angiotensin system.. PubMed. 2. 587–94. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Allison B. Lehtinen Breakdown of academic impact, for papers by Mariapina Pomilio Breakdown of academic impact, for papers by A L Blumberg Breakdown of academic impact, for papers by Lawrence Levine Breakdown of academic impact, for papers by P.E. Jennings Breakdown of academic impact, for papers by J A Lawson Breakdown of academic impact, for papers by Lucinda M. Wead Breakdown of academic impact, for papers by Glenn Solis Breakdown of academic impact, for papers by Kensaku Maeda Breakdown of academic impact, for papers by J. W. Strandhoy
Rankless by CCL
2026